A study of pre-operative (neoadjuvant) letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer: A preliminary safety report

MLA

John T. Carpenter, et al. “A Study of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Operable Breast Cancer: A Preliminary Safety Report.” Journal of Clinical Oncology, vol. 25, June 2007, p. 11020. EBSCOhost, https://doi.org/10.1200/jco.2007.25.18_suppl.11020.

APA

John T. Carpenter, J. Galleshaw, Andres Forero-Torres, H. Krontriras, Mansoor N. Saleh, C. Jones, Carla I. Falkson, I. Percent, Lisle Nabell, & J.F. De Los Santos. (2007). A study of pre-operative (neoadjuvant) letrozole in combination with bevacizumab in post-menopausal women with newly diagnosed operable breast cancer: A preliminary safety report. Journal of Clinical Oncology, 25, 11020. https://doi.org/10.1200/jco.2007.25.18_suppl.11020

Chicago

John T. Carpenter, J. Galleshaw, Andres Forero-Torres, H. Krontriras, Mansoor N. Saleh, C. Jones, Carla I. Falkson, I. Percent, Lisle Nabell, and J.F. De Los Santos. 2007. “A Study of Pre-Operative (Neoadjuvant) Letrozole in Combination with Bevacizumab in Post-Menopausal Women with Newly Diagnosed Operable Breast Cancer: A Preliminary Safety Report.” Journal of Clinical Oncology 25 (June): 11020. doi:10.1200/jco.2007.25.18_suppl.11020.